Table 6.
Clinical Outcome at Final Follow-up: With Concomitant Surgery.
| MACI Group |
BMAC Group |
|||||
|---|---|---|---|---|---|---|
| Scoresa | HTO | Realignment | None | HTO | Realignment | None |
| IKDC Subjective | 82.5 ± 8.86 | 72.58 ± 10.56 | 77.48 ± 9.22 | 82.63 ± 4.82 | 84.96 ± 6.17 | 80.19 ± 12.95 |
| IKDC Objective | 1A,1B,1C | 4A,4B | 5A,2B | 4A,1B | 5A | 2A,2B |
| KOOS Pain | 85 ± 6.24 | 76.12 ± 9.24 | 84.85 ± 15.60 | 93.4 ± 8.23 | 95.83 ± 6.64 | 93 ± 6.78 |
| KOOS Symptom | 84 ± 8.71 | 76.88 ± 9.97 | 84.57 ± 13.50 | 92.6 ± 12.79 | 92.67 ± 11.63 | 90.75 ± 5.96 |
| KOOS ADL | 84 ± 5.29 | 78.62 ± 10.97 | 85.85 ± 14.02 | 90.2 ± 10.13 | 95.67 ± 6.83 | 91 ± 7.78 |
| KOOS SRA | 74.33 ± 7.50 | 61.75 ± 11.18 | 73 ± 20.26 | 73 ± 17.53 | 86 ± 17.32 | 79.25 ± 21.56 |
| KOOS QOL | 80 ± 7 | 70 ± 18.79 | 79.71 ± 20.26 | 81.00 ± 12.94 | 88.5 ± 19.73 | 83.25 ± 9.25 |
| Tegner | 5.33 ± 1.52 | 4.87 ± 0.99 | 5.71 ± 1.25 | 6.4 ± 1.14 | 5.6 ± 0.89 | 6.25 ± 1.70 |
| VAS | 0.66 ± 0.57 | 0.87 ± 0.64 | 0.85 ± 0.89 | 0.8 ± 1.09 | 0 ± 0 | 0 ± 0 |
MACI = matrix-induced autologous chondrocyte implantation; BMAC = bone marrow aspirate concentrate; VAS = visual analog scale; IKDC = International Knee Documentation Committee; KOOS = Knee Injury Osteoarthritis Outcome Score; ADL = activities of daily living; SRA = sports and recreational activities; QOL = quality of life; HTO = high tibial osteotomy.
a
All scores are final follow-up scores with mean ± standard deviation values. The difference in improvement in the subgroups are nonsignificant (P = 0.999) in all scores, for both MACI and BMAC patients; exceptions are reported in text.